Copyright
©The Author(s) 2021.
World J Clin Cases. May 6, 2021; 9(13): 2951-2968
Published online May 6, 2021. doi: 10.12998/wjcc.v9.i13.2951
Published online May 6, 2021. doi: 10.12998/wjcc.v9.i13.2951
Reference | Patient number (n) | COVID-19 severity | COVID-19 complications | Mortality |
Qi et al[33] | 21 | N/A | ICU: 23.8% | 23.8% |
MV: 14.3% | ||||
Shock: 14.3% | ||||
ARDS: 28.6% | ||||
RRT: 9.5% | ||||
ECMO: 9.5% | ||||
Liu et al[32] | 17 | Mild1: 64.7% | ICU: 17.6% | 17.6% |
Severe1: 35.3% | MV: 11.8% | |||
Shock: 11.8% | ||||
ARDS: 29.4% | ||||
Iavarone[31] et al | 50 | N/A | ICU: 4% | 34% |
MV: 4% | ||||
Shock: 8% | ||||
ARDS: 52% | ||||
Sarin et al[14] | 43 | Severe2: 18.6% | ICU: 25.6% | 16.3% |
MV: 23.2% | ||||
Shock: 14% | ||||
Moon et al[19] | 103 | N/A | ICU: 23.3% | 39.8% |
MV: 17.5% | ||||
RRT: 4.9% | ||||
Lee et al[22] | 14 | N/A | ICU: 35.7%MV: 21.4% | 28.6% |
RRT: 7.1% | ||||
Shock: 28.6% | ||||
ARDS: 35.7% | ||||
Bajaj et al[23] | 37 | N/A | ICU: 43% | 30% |
MV: 38% | ||||
Shock: 30% | ||||
RRT: 19% | ||||
Kim et al[21] | 227 | N/A | Death, hospitalization, oxygen support, ICU, vasopressor support, or MV: 70.5% | 25.1% |
Shalimar et al[30] | 26 | Mild3: 57.7% | N/A | 42.3% |
Moderate3: 7.7% | ||||
Severe3: 34.6% | ||||
Marjot et al[18] | 386 | N/A | ICU: 28% | 32% |
MV: 18.4% | ||||
RRT: 5.4% | ||||
Jeon et al[28] | 67 | N/A | ICU: 3% | 9% |
Shock: 6% | ||||
RRT: 1.5% |
- Citation: Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives . World J Clin Cases 2021; 9(13): 2951-2968
- URL: https://www.wjgnet.com/2307-8960/full/v9/i13/2951.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i13.2951